4/A//SEC Filing
Lebovits Chaim 4/A
Accession 0001104659-24-084341
CIK 0001137883other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 4:07 PM ET
Size
9.4 KB
Accession
0001104659-24-084341
Insider Transaction Report
Form 4/AAmended
Lebovits Chaim
President & CEO
Transactions
- Purchase
Common Stock
2024-05-10$0.47/sh+20,000$9,300→ 1,079,865 total - Purchase
Common Stock
2024-05-13$0.49/sh+10,000$4,900→ 1,099,865 total - Purchase
Common Stock
2024-05-11$0.47/sh+10,000$4,665→ 1,089,865 total
Holdings
- 2,000,847(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.
- [F2]Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001406302
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 4:07 PM ET
- Size
- 9.4 KB